71 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
demonstrates our full commitment to solid execution and driving growth, as we continue in our work of delivering LUPKYNIS to patients in need.”
Earlier
8-K
EX-99.1
dc5ogecg11pl
15 Feb 24
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
6:06am
8-K
EX-99.1
9hc13neq8i0jop e1
2 Nov 23
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
6:01am
8-K
EX-10.1
yj53ge z5f397
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
S-8
x8jrvk lrfc
26 May 23
Registration of securities for employees
4:39pm
S-8
EX-10.1
uzsl zs8q1
25 Jun 21
Registration of securities for employees
4:31pm
8-K
EX-99.1
lytfbi9
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
dr6lgq7cg6mnafiy8sl
10 May 21
Definitive proxy
4:06pm
PRE 14A
f5k51vbv
27 Apr 21
Preliminary proxy
4:32pm
S-8
EX-5.1
fvxb 2l29lke
24 Feb 21
Registration of securities for employees
4:28pm
S-8
w341i
24 Feb 21
Registration of securities for employees
4:28pm